RRM1 and neoplasm: Furthermore, it regulates p53 and ribonucleotide reductase catalytic subunit M1 (RRM1) gene expression in PANC-1 and MIA PaCa-2 cells, which is relevant since gemcitabine resistance is associated with increased RRM1 expression, contributing to enhanced tumor cell proliferation [17].